Celldex Therapeutics reported $714.56M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
Agenus USD -199.08M 22.15M Jun/2026
Amgen USD 11.69B 2.5B Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Celldex Therapeutics USD 714.56M 258.34M Jun/2026
Glaxosmithkline GBP 17.42B 4.64B Mar/2026
Nektar Therapeutics USD 576.22M 486.38M Mar/2026
Northwest Biotherapeutics USD -50.54M 58.1M Mar/2026
Pfizer USD 85.19B 4.91B Jun/2026
Rigel Pharmaceuticals USD 117.61M 35.67M Sep/2025
Roche Holding CHF 32.69B 1.11B Jun/2026